HomeBusiness NewsNew Paper Offers Practical Roadmap for Using Real-World Data in FDA Drug...

New Paper Offers Practical Roadmap for Using Real-World Data in FDA Drug Approvals and Label Expansi…

September 25, 2026

- Advertisement -

BLUEBELL, Pa.–(BUSINESS WIRE)–Slipstream co-authors a new CPT paper with practical guidance for using real-world data in FDA drug approvals and label expansions.

Click here to view the original article.

Tags
Business Wire

- Advertisment -

New GCDLA committee invites practitioners to meet the judiciary – Proctor

WA news LIVE: Former Eagles star pays tribute to partner who died following childbirth; Four people charged over shooting in Perth’s south

New Paper Offers Practical Roadmap for Using Real-World Data in FDA Drug Approvals and Label Expansi…

Recently Viewed

Derek Dyson to lead WTFN’s newly combined Radar Studios

Inside The Ultra‑Rare Riverfront Penthouses Changing How Brisbane Buys Luxury

Umpires Hayden Meyer and Brett Rosebury locked in for AFL grand final

Fraser Yachts’ CEO on the Future of Luxury Yachting

FEATURED

Great White shark bites fishing boat off Sunshine Coast

Volcanic cloud from Whakaari White Island halts flights

Great Koala Count: Aussies urged to track sightings of iconic marsupials

POPULAR POSTS

Xero vs Life360: Which ASX tech share has more upside?

Cystic fibrosis: Triple therapy is particularly effective in early childhood

A Georgia prison program is giving hard-to-place rescue dogs a second chance while giving incarcerated men a new sense of purpose. More than 120...

POPULAR CATEGORY

FOLLOW US

New Paper Offers Practical Roadmap for Using Real-World Data in FDA Drug Approvals and Label Expansi…

RELATED ARTICLES

Recently Viewed

FEATURED

POPULAR POSTS

POPULAR CATEGORY

FOLLOW US